BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P1H REFRESH-INTERVAL:P1H CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU DTSTART:20070101T000000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU DTSTART:20070101T000000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20260416T150000 DTEND;TZID=America/New_York:20260416T160000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:Historic Marijuana Reclassification: Changes & Implications DESCRIPTION:From Schedule 1 to Schedule 3: What does marijuana rescheduling mean for your organization?An executive order reclassifying medical marijuana was issued at the end of 2025\, marking a historic shift with far-reaching implications for healthcare. Join us as we explore the impact this may have on organizational marijuana policies\, employee use\, patient care\, drug testing\, accommodations\, HIPAA considerations\, and key HR and business decisions so your agency can respond proactively and compliantly. KEY WEBINAR TAKEAWAYSHow historic marijuana rescheduling does and does not impact hospice and home care company employees\, patients\, and business processesCurrent legal status of medical marijuana in light of historic reschedulingHow reclassification affects your marijuana policy and procedures BONUS MATERIALSWhitepaper: Marijuana Policy & Best Practices: Handling Employee Medical & Recreational UseMarijuana Rules: Guidelines for Creating Effective Cannabis Policy & Procedures WEBINAR DETAILSAt year-end 2025\, the long-awaited rescheduling of marijuana took a big step forward when President Trump signed an executive order reclassifying medical marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol with Codeine No. 3). Once enshrined as law\, the historic rescheduling of medical marijuana will favorably impact the cannabis industry and potentially could impact hospices and home care companies. This webinar will discuss what marijuana reclassification does (and does not) mean for the healthcare industry. Learn what this rescheduling means (or does not mean) for your organization's marijuana policy\, people\, patients\, testing program\, terminations\, accommodations\, and other HR\, HIPAA\, and business issues.\nTHIS WEBINAR WILL BENEFIT THE FOLLOWING AGENCIES:HospiceHome CareHome HealthPalliative Care WHO SHOULD ATTEND?ComplianceHRTrainingLegalManagers and executivesAnyone responsible for workplace policy and compliance TAKE-AWAY TOOLKITEmployee training logInteractive quizPDF of slides and speaker's contact info for follow-up questionsAttendance certificate provided to self-report CE credits\nNOTE: All materials are subject to copyright. Transmission\, retransmission\, or republishing of any webinar to other institutions or those not employed by your institution is prohibited. Print materials may be copied for eligible participants only.Presented ByNancy FlynnThe ePolicy Institute \, Business Writing Institute & Marijuana Policy Institute X-ALT-DESC;FMTTYPE=text/html:

From Schedule 1 to Schedule 3: What does marijuana rescheduling mean for your organization?

An executive order reclassifying medical marijuana was issued at the end of 2025\, marking a historic shift with far-reaching implications for healthcare. Join us as we explore the impact this may have on organizational marijuana policies\, employee use\, patient care\, drug testing\, accommodations\, HIPAA considerations\, and key HR and business decisions so your agency can respond proactively and compliantly.

 \;

KEY WEBINAR TAKEAWAYS

 \;

BONUS MATERIALS

 \;

WEBINAR DETAILS

At year-end 2025\, the long-awaited rescheduling of marijuana took a big step forward when President Trump signed an executive order reclassifying medical marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol®\; with Codeine No. 3). Once enshrined as law\, the historic rescheduling of medical marijuana will favorably impact the cannabis industry &mdash\; and potentially could impact hospices and home care companies. This webinar will discuss what marijuana reclassification does (and does not) mean for the healthcare industry. Learn what this rescheduling means (or does not mean) for your organization&rsquo\;s marijuana policy\, people\, patients\, testing program\, terminations\, accommodations\, and other HR\, HIPAA\, and business issues.


THIS WEBINAR WILL BENEFIT THE FOLLOWING AGENCIES:

 \;

WHO SHOULD ATTEND?

 \;

TAKE-AWAY TOOLKIT


NOTE: All materials are subject to copyright. Transmission\, retransmission\, or republishing of any webinar to other institutions or those not employed by your institution is prohibited. Print materials may be copied for eligible participants only.

Presented By

Nancy Flynn

The ePolicy Institute&trade\;\, Business Writing Institute&trade\; &\; Marijuana Policy Institute&trade\;

 \;


 \;

LOCATION: UID:e.4140.1409632 SEQUENCE:3 DTSTAMP:20260417T010438Z URL:https://members.mhha.org/events/Details/historic-marijuana-reclassification-changes-implications-1665783?sourceTypeId=Hub END:VEVENT END:VCALENDAR